help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gudelsky, G. A.
Right arrow Articles by Porter, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gudelsky, G. A.
Right arrow Articles by Porter, J. C.

Endocrinology, Vol 108, 440-444, Copyright © 1981 by Endocrine Society


ARTICLES

Role of estrogen in the dopaminergic control of prolactin secretion

GA Gudelsky, DD Nansel and JC Porter

The effect of estrogen on the dopaminergic control of PRL secretion was investigated. Treatment of ovariectomized rats with estradiol benzoate (25 microgram/kg, sc) daily for 5 days resulted in a marked elevation of the serum PRL concentration. This estrogen-induced increase in serum PRL levels was apparently not the result of a suppressed release of dopamine into hypophysial portal blood, since the mean dopamine concentration in hypophysial portal plasma in estrogen-treated rats was 2.5 times that in vehicle-treated animals. It was found that under in vitro conditions, dopamine was much less effective in inhibiting the release of PRL from pituitary glands of estrogen-treated rats than from glands of vehicle-treated controls. The capacity of PRL cells to internalize dopamine and incorporate it into PRL secretory granules was evaluated in anterior pituitary tissue obtained from estrogen- or vehicle-treated animals. When tissue fragments of the anterior pituitary gland were incubated in the presence of dopamine (10(-5) M) for 30 min at 37 C and then homogenized and fractionated by means of continuous sucrose density gradient centrifugation, it was found that the amount of dopamine associated with PRL granules from anterior lobe tissue of estrogen-treated rats was only 40% of that from the tissue of vehicle-treated controls. These results are supportive of the hypothesis that the ability of estrogen to antagonize the inhibitory action of dopamine on PRL secretion is mediated through an estrogen- induced reduction in the capacity of the PRL cell to incorporate dopamine into PRL secretory granules. (Endocrinology 108: 440, 1981)


This article has been cited by other articles:


Home page
ReproductionHome page
A M Brown, J M Janik, E S Murphree, R King, and P Callahan
Effects of cyclic steroid hormone replacement on prolactin and luteinizing hormone surges in female rats
Reproduction, September 1, 2004; 128(3): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Yokoyama, W. C. Kitchens, B. Toth, M. G. Schwacha, K. I. Bland, and I. H. Chaudry
Upregulation of hepatic prolactin receptor gene expression by 17{beta}-estradiol following trauma-hemorrhage
J Appl Physiol, December 1, 2003; 95(6): 2530 - 2536.
[Abstract] [Full Text]


Home page
ScienceHome page
M Sar
Estradiol is concentrated in tyrosine hydroxylase-containing neurons of the hypothalamus
Science, March 2, 1984; 223(4639): 938 - 940.
[Abstract] [PDF]


Home page
ScienceHome page
D. Sarkar, P. Gottschall, and J Meites
Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors
Science, November 12, 1982; 218(4573): 684 - 686.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society